Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, May 14, 2013 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today reported its financial results for the three months ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
SAN DIEGO, May 14, 2013 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today reported its financial results for the three months ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
